Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 57
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
La maladie hémolytique du foetus et du nouveau-né et thrombopénie immune périnatale | Clarke G, Hannon J | 2018 | Guide de la pratique transfusionnelle | View La maladie hémolytique du foetus et du nouveau-né et thrombopénie immune périnatale | Health care providers | Other |
ResearchUnit: How does anti-D prevent hemolytic disease of the fetus and newborn? Lessons from a mouse model | Lazarus A | 2018 | Blood.ca website | View ResearchUnit: How does anti-D prevent hemolytic disease of the fetus and newborn? Lessons from a mouse model | Other | Other |
Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH | Ragni MV, Croteau SE, Morfini M, Cnossen MH, Iorio A | 2018 | J Thromb Haemost | View Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH | Health care providers | Basic research |
Heparin-induced thrombocytopenia-associated thrombosis: from arterial to venous to venous limb gangrene | Warkentin TE | 2018 | J Thromb Haemost | View Heparin-induced thrombocytopenia-associated thrombosis: from arterial to venous to venous limb gangrene | Health care providers | Benchmarking and standard setting |
Donor deferral policies for men who have sex with men: past, present and future | Goldman M, Shih AW, O'Brien SF, Devine D | 2018 | Vox Sang | View Donor deferral policies for men who have sex with men: past, present and future | Health care providers | MSM research |
Risk of exposure to Zika virus and impact on cord blood banking and adult unrelated donors in hematopoietic cell transplantation: the Canadian Blood Services experience | Adams Z, Morris G, Campbell T, Mostert K, Dibdin N, Fearon M, Elmoazzen H, Mercer D, Young K, Allan D | 2018 | Biol Blood Marrow Transplant | View Risk of exposure to Zika virus and impact on cord blood banking and adult unrelated donors in hematopoietic cell transplantation: the Canadian Blood Services experience | Blood operators | Clinical research |
Splenectomy for immune thrombocytopenia: down but not out | Chaturvedi S, Arnold DM, McCrae KR | 2018 | Blood | View Splenectomy for immune thrombocytopenia: down but not out | Health care providers | Clinical research |
Concentré de recherche : Une façon nouvelle d'évaluer la qualité des globules rouges | Acker J | 2018 | Blood.ca website | View Concentré de recherche : Une façon nouvelle d'évaluer la qualité des globules rouges | Researchers | Clinical research |
Differential diagnoses for sepsis?induced disseminated intravascular coagulation: communication from the SSC of the ISTH | Iba T, Levy J, Wada H, Thachil J, E. Warkentin T, Levi M, Subcommittee on Disseminated Intravascular Coagulation | 2018 | J Thromb Haemost | View Differential diagnoses for sepsis?induced disseminated intravascular coagulation: communication from the SSC of the ISTH | Other | Benchmarking and standard setting |
Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT | Krauel K, Preuße P, Warkentin TE, Trabhardt C, Brandt S, Jensch I, Mandelkow M, Hammer E, Hammerschmidt S, Greinacher A | 2018 | Blood | View Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT | Researchers | Basic research |
Surveillance Report 2017 | O'Brien S | 2018 | Blood.ca website | View Surveillance Report 2017 | Other | Other |
Blood coagulation dissected | Pryzdial ELG, Lee FMH, Lin BH, Carter RLR, Tegegn TZ, Belletrutti MJ | 2018 | Transfus Apher Sci | View Blood coagulation dissected | Health care providers | Other |
Concentré de recherche: Rôle du groupe sanguin dans le déclenchement d'une hémolyse après l'administration d'immunoglobulines | Branch D | 2018 | Blood.ca website | View Concentré de recherche: Rôle du groupe sanguin dans le déclenchement d'une hémolyse après l'administration d'immunoglobulines | Researchers | Basic research |
Pathogen inactivation strategies to improve blood safety: Let's not throw pathogen-reduced platelets out with their bath water | Devine DV | 2018 | JAMA Oncol | View Pathogen inactivation strategies to improve blood safety: Let's not throw pathogen-reduced platelets out with their bath water | Researchers | New or improved product or process |
Circular of information for the use of human blood components: Plasma components | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Plasma components | Health care providers | Benchmarking and standard setting |
Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin | MacIsaac J, Siddiqui R, Jamula E, Li N, Baker S, Webert KE, Evanovitch D, Heddle NM, Arnold DM | 2018 | Transfusion | View Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin | Researchers | Clinical research |
Therapeutic Apheresis | Pavenski K | 2018 | Clinical Guide to Transfusion | View Therapeutic Apheresis | Health care providers | Benchmarking and standard setting |
Blood bag spiking procedure | Shimla S, Jenkins C, McTaggart K | 2018 | Blood.ca website | View Blood bag spiking procedure | Other | Other |
GPIb? is required for platelet-mediated hepatic thrombopoietin generation | Xu M, Li J, Neves MAD, Zhu G, Carrim N, Yu R, Gupta S, Marshall J, Rotstein O, Peng J, Hou M, Kunishima S, Ware J, Branch DR, Lazarus A, Ruggeri ZM, Freedman J, Ni H | 2018 | Blood | View GPIb? is required for platelet-mediated hepatic thrombopoietin generation | Researchers | Basic research |
Comorbidities in persons with haemophilia aged 60 years or more compared with age-matched people from the general population | Marchesini E, Oliovecchio E, Coppola A, Santagostino E, Radossi P, Castaman G, Valdre L, Santoro C, Tagliaferri A, Ettorre C, Zanon E, Barillari G, Cantori I, Caimi TM, Sottilotta G, Iorio A, Mannucci PM | 2018 | Haemophilia | View Comorbidities in persons with haemophilia aged 60 years or more compared with age-matched people from the general population | Health care providers | Clinical research |
Red blood cell antibody induced anemia causes differential degrees of tissue hypoxia in kidney and brain | Mistry N, Mazer CD, Sled JG, Lazarus AH, Cahill LS, Solish M, Zhou Y-Q, Romanova N, Hare AG, Doctor A, Fisher JA, Brunt KR, Simpson JA, Hare GMT | 2018 | Am J Physiol Regul Integr Comp Physiol | View Red blood cell antibody induced anemia causes differential degrees of tissue hypoxia in kidney and brain | Researchers | Basic research |
The Massive Online Needs Assessment (MONA) to inform the development of an emergency haematology educational blog series | Chan TM, Jo D, Shih AW, Bhagirath VC, Castellucci LA, Yeh C, Thoma B, Tseng EK, de Wit K | 2018 | Perspect Med Educ | View The Massive Online Needs Assessment (MONA) to inform the development of an emergency haematology educational blog series | Health care providers | Education research |
Effect of liposome treatment on hemorheology and metabolic profile of human red blood cells during hypothermic storage | Da Silveira Cavalcante L, Acker J, Holovati J | 2018 | Biopreserv Biobank | View Effect of liposome treatment on hemorheology and metabolic profile of human red blood cells during hypothermic storage | Researchers | Basic research |
Pathophysiology of immune thrombocytopenia | Li J, Sullivan JA, Ni H | 2018 | Curr Opin Hematol | View Pathophysiology of immune thrombocytopenia | Researchers | Other |
Importance du fer chez les donneurs de sang total : la perspective canadienne | Pambrun C, Goldman M | 2018 | Blood.ca website | View Importance du fer chez les donneurs de sang total : la perspective canadienne | Health care providers | Other |
rIgG1 Fc hexamer inhibits antibody-mediated autoimmune disease via effects on complement and FcgammaRs | Spirig R, Campbell IK, Koernig S, Chen CG, Lewis BJB, Butcher R, Muir I, Taylor S, Chia J, Leong D, Simmonds J, Scotney P, Schmidt P, Fabri L, Hofmann A, Jordi M, Spycher MO, Cattepoel S, Brasseit J, Panousis C, Rowe T, Branch DR, Baz Morelli A, Kasermann F, Zuercher AW | 2018 | J Immunol | View rIgG1 Fc hexamer inhibits antibody-mediated autoimmune disease via effects on complement and FcgammaRs | Researchers | Basic research |
Concentré de recherche : Plasma : c'est dans la poche | Sheffield W, Jenkins C | 2018 | Blood.ca website | View Concentré de recherche : Plasma : c'est dans la poche | Researchers | Basic research |
Neutropenia and monocytopenia in recurrent anaphylactoid reactions after red blood cell transfusions in a woman with immunoglobulin A (IgA) deficiency and anti-IgA | Warkentin TE, Morin P-A, Heddle NM | 2018 | Transfusion | View Neutropenia and monocytopenia in recurrent anaphylactoid reactions after red blood cell transfusions in a woman with immunoglobulin A (IgA) deficiency and anti-IgA | Health care providers | Clinical research |
Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection | Greco-Stewart V, Kiernan J, Killeen D, Haun S, Mercer D, Young K, Liwski RS, Allan DS | 2018 | Transfusion | View Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection | Health care providers | Clinical research |
Immune Globulin Products | Harding R, Lazarus A | 2018 | Clinical Guide to Transfusion | View Immune Globulin Products | Health care providers | Other |
Improving quality of care for patients with iron deficiency anemia presenting to the emergency department | Khadadah F, Callum J, Shelton D, Lin Y | 2018 | Transfusion | View Improving quality of care for patients with iron deficiency anemia presenting to the emergency department | Health care providers | Clinical research |
Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia | Nazy I, Clare R, Staibano P, Warkentin TE, Larché M, Moore JC, Smith JW, Whitlock RP, Kelton JG, Arnold DM | 2018 | J Thromb Haemost | View Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia | Researchers | Clinical research |
Modulating Intracellular Ice Growth with Cell-Permeating Small-Molecule Ice Recrystallization Inhibitors | Poisson JS, Acker JP, Briard JG, Meyer JE, Ben RN | 2018 | Langmuir | View Modulating Intracellular Ice Growth with Cell-Permeating Small-Molecule Ice Recrystallization Inhibitors | Researchers | Basic research |
The Monocyte Monolayer Assay: Past, Present and Future | Tong TN, Cen S, Branch DR | 2018 | Transfus Med Rev | View The Monocyte Monolayer Assay: Past, Present and Future | Researchers | Basic research |
Blood and clots series: My patient has a pulmonary embolism. Should I screen them for cancer? | Tseng E | 2018 | CanadiEM website | View Blood and clots series: My patient has a pulmonary embolism. Should I screen them for cancer? | Health care providers | Benchmarking and standard setting |
Microfluidic determination of lymphocyte vascular deformability: effects of intracellular complexity and early immune activation | Kang N, Guo Q, Islamzada E, Ma H, Scott MD | 2018 | Integr Biol | View Microfluidic determination of lymphocyte vascular deformability: effects of intracellular complexity and early immune activation | Researchers | Basic research |
Timing of gamma irradiation and blood donor sex influences in vitro characteristics of red blood cells | de Korte D, Thibault L, Handke W, Harm SK, Morrison A, Fitzpatrick A, Marks DC, Yi QL, Acker JP | 2018 | Transfusion | View Timing of gamma irradiation and blood donor sex influences in vitro characteristics of red blood cells | Blood operators | New or improved product or process |
Two-year follow-up of donors in a large national study of ferritin testing | Goldman M, Uzicanin S, Osmond L, Yi Q-L, Scalia V, O'Brien SF | 2018 | Transfusion | View Two-year follow-up of donors in a large national study of ferritin testing | Researchers | Clinical research |
Protocol for a phase III, non-inferiority, randomised comparison of a new fibrinogen concentrate versus cryoprecipitate for treating acquired hypofibrinogenaemia in bleeding cardiac surgical patients: the FIBRES trial | Karkouti K, Callum J, Rao V, Heddle N, Farkouh ME, Crowther MA, Scales DC | 2018 | BMJ Open | View Protocol for a phase III, non-inferiority, randomised comparison of a new fibrinogen concentrate versus cryoprecipitate for treating acquired hypofibrinogenaemia in bleeding cardiac surgical patients: the FIBRES trial | Researchers | Clinical research |
Investigations for fetal and neonatal alloimmune thrombocytopenia: communication from the SSC of the ISTH | Petermann R, Bakchoul T, Curtis BR, Mullier F, Miyata S, Arnold DM, Subcommittee on platelet immunology | 2018 | J Thromb Haemost | View Investigations for fetal and neonatal alloimmune thrombocytopenia: communication from the SSC of the ISTH | Health care providers | Benchmarking and standard setting |
Transfusion de plaquettes, l'allo-immunisation et la prise en charge de l'état réfractaire aux plaquettes | Zeller M, Petraszko T | 2018 | Guide de la pratique transfusionnelle | View Transfusion de plaquettes, l'allo-immunisation et la prise en charge de l'état réfractaire aux plaquettes | Health care providers | Other |
Targeting transfusion-related acute lung injury: the journey from basic science to novel therapies | Semple JW, McVey MJ, Kim M, Rebetz J, Kuebler WM, Kapur R | 2018 | Crit Care Med | View Targeting transfusion-related acute lung injury: the journey from basic science to novel therapies | Researchers | Basic research |
Hemolytic Disease of the Fetus and Newborn and Perinatal Immune Thrombocytopenia | Clarke G, Hannon J | 2018 | Clinical Guide to Transfusion | View Hemolytic Disease of the Fetus and Newborn and Perinatal Immune Thrombocytopenia | Health care providers | Other |
Concentré de recherche: Comment l'anti-D est-il capable d'empêcher la maladie hémolytique du foetus et du nouveau-né? Réponses à l'aide d'un modèle murin | Lazarus A | 2018 | Blood.ca website | View Concentré de recherche: Comment l'anti-D est-il capable d'empêcher la maladie hémolytique du foetus et du nouveau-né? Réponses à l'aide d'un modèle murin | Other | Other |
Natural, not immune; classical, not alternative | Warkentin TE | 2018 | Blood | View Natural, not immune; classical, not alternative | Researchers | Other |
A brief survey of clinicians' perceptions of parent preferences for involvement in obstetrical and perinatal management decisions in haemophilia | Lucier KJ, Movilla RV, Parvizian MK, Siddiqui R, Gabriele EH, Bourque M, MacIsaac J, Moorehead PC, Chan AK, Heddle NM, Lane SJ | 2018 | Haemophilia | View A brief survey of clinicians' perceptions of parent preferences for involvement in obstetrical and perinatal management decisions in haemophilia | Health care providers | Clinical research |
Endothelial-Specific Deletion of Autophagy Related 7 (ATG7) Attenuates Arterial Thrombosis in Mice | Yau JW, Singh KK, Hou Y, Lei X, Ramadan A, Quan A, Teoh H, Kuebler WM, Al-Omran M, Yanagawa B, Ni H, Verma S | 2017 | J Thorac Cardiovasc Surg | View Endothelial-Specific Deletion of Autophagy Related 7 (ATG7) Attenuates Arterial Thrombosis in Mice | Researchers | Basic research |
Experiences with semi-routine production of riboflavin and UV-B pathogen-inactivated platelet concentrates in three blood centres | van der Meer PF, Couture C, Hervig T, Kruit G, Devine DV, de Korte D, Kerkhoffs JL | 2017 | Vox Sang | View Experiences with semi-routine production of riboflavin and UV-B pathogen-inactivated platelet concentrates in three blood centres | Blood operators | New or improved product or process |
Immunocamouflaged RBC for alloimmunized patients | Scott M, Toyofuku W, Yang X, Raj M, Kang N | 2017 | Transfusion Medicine and Scientific Developments | View Immunocamouflaged RBC for alloimmunized patients | Researchers | Basic research |
Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement | Iorio A, Iserman E, Blanchette V, Dolan G, Escuriola Ettingshausen C, Hermans C, Negrier C, Oldenburg J, Reininger A, Rodriguez-Merchan C, Spannagl M, Valentino LA, Young G, Steinitz-Trost KN, Gringeri A | 2017 | Haemophilia | View Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement | Health care providers | Clinical research |